Key facts
- Notable investors include Cowin Capital, SND Ventures Group, Huzhou Xunshang Venture Capital, Nanhui Venture Capital, Suzhou Zehe Investment Management — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Haogerui
- ·The full record, as it builds
Funding rounds
No funding rounds for Haogerui are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Haogerui
Manufacturer and developer of end medical devices designed for diagnostic purposes. The company offers liquid metal bearing tube assemblies, cathode structures, and high-power imaging cores, enabling medical imaging markets to achieve improved durability, higher efficiency, and enhanced localization of advanced diagnostic equipment.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Haogerui doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Haogerui shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Haogerui in its N-PORT filings yet. We sweep new filings monthly.